近 60 亿美元!不到十天两起小核酸授权出海

医麦客
Feb 13

免费早鸟票,200 张限量领取2026 年 2 月 13 日医麦客新闻 eMedClub News2 月 11 日,瑞博生物宣布与全球 MASH 领域领军企业 Madrigal Pharmaceuticals 达成全球独家许可协议,双方将基于其自主研发的肝靶向 RiboGalSTAR™ 平台,联合开发六款针对代谢功能障碍相关脂肪性肝炎(MASH)的创新 siRNA 疗法,共同布局这一全球高度未满足...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10